BACKGROUND: Intracranial pressure (ICP) monitoring is a cornerstone of care for severe traumatic brain injury (TBI). Management of ICP can help ensure adequate cerebral blood flow and oxygenation. However, studies indicate that brain hypoxia may occur despite normal ICP and the relationship between ICP and brain oxygenation is poorly defined. This is particularly important for children in whom less is known about intracranial dynamics. OBJECTIVE: To examine the relationship between ICP and partial pressure of brain tissue oxygen (PbtO2) in children with severe TBI (Glasgow Coma Scale score #8) admitted to Red Cross War Memorial Children's Hospital, Cape Town.
T raumatic brain injury (TBI) is a major contributor to the burden of disease in children and adults worldwide. 1, 2 The poor outcome associated with severe TBI may be improved by effective medical care, which in large part aims to prevent or ameliorate secondary insults. [3] [4] [5] [6] [7] Currently, intracranial pressure (ICP) monitoring and management are a cornerstone of treatment for severe TBI. Increased ICP is common after TBI and may exacerbate the primary injury through local tissue pressure effects, reduction in cerebral perfusion pressure (CPP) and compromised brain metabolism, including brain oxygenation. One of the major reasons to treat ICP, therefore, is to ensure adequate brain perfusion and avoid ischemia. Brain ischemia is an important secondary injury after TBI and may increase the risk of death or disability in these patients. 8 Therefore, prompt detection and treatment of ischemia may minimize the potential for irreversible brain damage.
Observational clinical studies using direct measures of brain oxygen, such as partial pressure of brain tissue oxygen (PbtO2), have found that reduced PbtO2 is associated with poor outcome in both adult and pediatric TBI. [10] [11] [12] [13] [14] [15] However, direct measures of brain perfusion or oxygenation are not routinely used in the management of patients with severe TBI, especially not in children.
Recent evidence has suggested that reduced PbtO2 may occur despite apparently adequate ICP and CPP control in both adults and children with TBI. [16] [17] [18] In particular, very low brain tissue oxygen (PbtO2 ,10 mm Hg/1.33 kPa) may occur in as many as one third of children with severe TBI despite adherence to current international management guidelines. 18 These episodes appear to be important because reduced PbtO2 is associated with poor outcome and the association between ICP and poor outcome may, in part, be explained by reduced PbtO2. 12 In some patients it is apparent that ICP control is directly associated with improved PbtO2, ie, there is an inverse relationship between ICP and PbtO2. For example, refractory increased ICP tends to be associated with low PbtO2 that responds to decompressive craniectomy in both adult 19 and pediatric 20 TBI. On the other hand, other factors may cause parallel changes in ICP and PbtO2. For example, hyperemia could theoretically increase both ICP and PbtO2 simultaneously, and so the relationship between these 2 variables may not always be as expected.
The relationship between ICP and PbtO2 has important implications for treatment protocols, particularly because monitors for brain perfusion or oxygenation are not yet recommended for children in international guidelines. A better understanding of the relationship between ICP and PbtO2 therefore may be of value. This is of particular importance for children in whom the interpretation of intracranial relationships may be more complex than in adults. Therefore, we sought to examine the relationship between ICP and PbtO2 in a large cohort of children with severe TBI. Specifically, we aimed to (1) examine the relationship between ICP and PbtO2 from time-linked paired observations of these variables, (2) explore various critical thresholds for ICP and PbtO2, and (3) examine digital data trends depicting the relationship between ICP and PbtO2.
METHODS
Approval for this study was obtained from the institutional review board of the University of Cape Town. Patient consent for inclusion in the study was obtained from the next of kin.
Patient Selection
This was a retrospective study of prospectively collected data for all children who underwent ICP and PbtO2 monitoring for severe TBI (postresuscitation Glasgow Coma Scale score of #8) from June 2006 to June 2009. All patients were younger than 15 years old.
ICP and PbtO2 Monitors
ICP was measured with an intraparenchymal monitor (Codman ICP Express; Codman, Raynham, Massachusetts) or Camino (Integra Neurosciences, Plainsboro, New Jersey). ICP catheters were placed on the same side as PbtO2 monitors (Licox; Integra Neurosciences) in normalappearing white matter on head computed tomography scan in the right frontal lobe or in the more injured hemisphere. Correct position of the catheters was confirmed on follow-up computed tomography. Intracranial monitoring was started as soon as possible after admission and continued until ICP and PbtO2 were stable for more than 24 hours without treatment other than sedation for ventilator care or until the patient died.
Patient Care
Patients were cared for using a local algorithm based on current recommendations for the management of TBI in children. 21 All patients with severe TBI are resuscitated on admission, intubated, and mechanically ventilated in the pediatric intensive care unit. Significant intracranial hematomas are immediately surgically evacuated. Increased ICP (.20 mm Hg/2.67 kPa) is treated in a stepwise fashion. 22, 23 In general, we aim to keep CPP greater than 50 mm Hg/6.6 kPa in children older than 2 years of age and more than 45 mm Hg/5.9 kPa in children younger than 2 years of age. Reduced PbtO2 is defined as less than 20 mm Hg (,2.67 kPa) 11 and is treated using an algorithmic approach, beginning with identification of the cause for reduced PbtO2, which was reported elsewhere. 12 
Data Collection
Time-linked data of physiological parameters were extracted from the hourly recordings taken in the intensive care unit (75 patients). Since April 2008, ICP and PbtO2 data were also captured using a computerized software recording system (ICMPlus; Cambridge University, Cambridge, United Kingdom) that sampled variables at 50 Hz. From this raw data file, variables were averaged over 10 seconds, and these 10-second averages were used for subsequent data analysis. Among this cohort of 75 patients, we had 30 patients who had complete data sets from continuous recording that had been manually cleaned of all artifacts. The first 2 hours of PbtO2 monitoring data were discarded to allow for probe stabilization. Data were excluded from patients who were terminal on admission (brain dead or Glasgow Coma Scale score of 3 with fixed dilated pupils who died within the first 12 hours), from beyond the first hour of PbtO2 = 0, from catheters placed incorrectly or that were in a pericontusional location, and when recorded during tests, such as autoregulation and ventilation tests.
Data Analysis
Data were analyzed using several different analyses, including the timelinked relationship between ICP and PbtO2, controlling for other variables, overall critical thresholds of ICP, age-related thresholds of ICP, and thresholds for individual patients. Statistical significance was set at 0.05 for all analyses, and data were analyzed using SPSS version 19.0 (SPSS Inc, Chicago, Illinois). We examined 2 groups of data. In group A, we examined hourly variables recorded from the nursing observations of all patients (N = 75). Although these were only hourly data samples, they allowed a larger cohort of patients to be examined. A previous analysis done by our group (unpublished data) using a Bland-Altman plot showed that for hourly and continuously recorded data, 95% of values were in agreement. However, within this group, we also had 30 patients for whom we had high-frequency data (group B). After manual cleaning, we had more than 1 million time points for all variables to examine separately in this group for finer analysis.
Time-Linked Relationship Between ICP and PbtO2
Analyses were conducted in a sequential manner, starting with raw data of paired ICP and PbtO2 observations, followed by increasingly defined analyses to explore different methods of analyzing the relationship between these 2 variables.
The General Relationship Between ICP and PbtO2
Paired observations for ICP and PbtO2 were examined with Spearman's correlation and a generalized estimating equation (GEE) model to control for interindividual variation. Simple logistic regression was conducted using PbtO2 dichotomized at 10 mm Hg as the dependent variable because this threshold has a well-described independent association with poor outcome. [10] [11] [12] 14, 24, 25 We examined the impact of several other factors that may influence this relationship, including whether patients had a monitor placed on the side of a significant contusion, whether a craniotomy/craniectomy had been performed, and the time after injury. Where we used continuous data, we also checked for the possibility that a lag-phase difference in the PbtO2 response may influence our results by reanalyzing the data with the PbtO2 values offset by 10 and 20 seconds.
Relationship Between ICP and PbtO2 Controlled for Systemic Variables
To examine the possible influence of confounding variables, we used multiple linear regression and a GEE model to control for mean arterial pressure, PaO 2 , PaCO 2 , and hemoglobin. For this analysis, we only used ICP and PbtO2 data from time points when observations for these other variables were available, ie, when arterial blood gases were taken.
Critical Threshold Values of ICP and PbtO2
Values for ICP were examined in 5 mm Hg-increments to determine whether critical ICP thresholds for changes in PbtO2 could be defined. Given that various studies have reported different thresholds for PbtO2 in association with outcome and the fact that although our treatment threshold for PbtO2 was 20 mm Hg, episodes of lower PbtO2 were common and PbtO2 less than 10 mm Hg had a stronger association with poor outcome in earlier work at our institution, 12 we examined the sensitivity and specificity of these ICP thresholds against several PbtO2 thresholds in 5 mm Hg-increments from 5 mm Hg to 20 mm Hg. The relative risks for each threshold of ICP for the different thresholds of PbtO2 were calculated. To determine which ICP threshold level would provide the best balance between sensitivity and specificity to detect reduced PbtO2, receiveroperating characteristic (ROC) curves were constructed. The ROC curve displays the efficacy of a range of tests (in this case, ICP thresholds) by plotting sensitivity against 1-specificity with both axes ranging from 0 to 1. The diagonal of such a graph denotes that the test in question would accurately predict disease (in this case, PbtO2 below threshold) with no greater power than chance. The area under the curve equals the probability that a random sample with a positive result has a higher value than a random sample with a negative result and equals 0.5 under the diagonal (null hypothesis). The effectiveness of a test to detect disease would be found by examining how far the curve lies away from the diagonal in the direction of the y axis and is indicated by the area under the curve, where the perfect curve would have an area of 1.0. 26, 27 ROC curves were constructed for ICP against PbtO2 less than 5 mm Hg, less than 10 mm Hg, and less than 20 mm Hg.
Age-Related Thresholds
Because children are developing physiologically and may have different normative values for ICP at different ages, we also considered that age may influence our results. To date, there are few robust data on age-related ICP treatment thresholds, and no recommendations of specific age-related thresholds for ICP treatment are outlined in the pediatric TBI guidelines. We used data from Chambers et al, 28 who assessed ICP thresholds in association with outcome. Accordingly, our cohort was divided into the following age categories, for which the respective ICP thresholds were adopted: 2 to 6 years (6 mm Hg), 7 to 10 years (9 mm Hg), and 11 to 14 years (13 mm Hg). ROC curves were plotted for each age group.
To calculate the sensitivity and specificity of these age-related thresholds for reduced PbtO2, threshold ICP values for each group were designated by the symbol X (therefore X = 6, 9, or 13 mm Hg depending on the age category). PbtO2 was dichotomized at 10 mm Hg. These dichotomized data for each patient were then sorted for (1) ICP , X, and ICP $ X, (2) ICP , (X 1 5) and ICP $ (X 1 5), and (3) ICP , (X 1 10) and ICP $ (X 1 10). Therefore, data were examined using 3 ICP levels: age threshold, age threshold 1 5 mm Hg, and age threshold 1 10 mm Hg.
Relationship Between ICP and PbtO2 in Individual Patients
Because TBI may have significant interindividual heterogeneity and because examination of data in a large cohort may mask significant relationships seen in individual patients, additional ROC curves for individual patients were constructed using hourly and electronic data (where available).
Relationship Between ICP and PbtO2 in Individual Patients at Selected Time Points
Because of temporal heterogeneity in TBI, it is possible that the relationship between ICP and PbtO2 when averaged over a long time period, even in a single patient, may appear weak, but may demonstrate a stronger relationship when examined over a more limited time frame. Therefore, electronic data trends for individual patients were reviewed to select examples of the dynamic relationship between ICP and PbtO2. Data were manually reviewed to exclude artifacts and any observations related to external manipulation.
RESULTS
Data for 81 patients who underwent ICP and PbtO2 monitoring for severe TBI from June 2006 to June 2009 were reviewed. Sixteen percent of the data (1601 hours) were excluded for the following reasons: poor placement or penumbral probe location (n = 3 patients), the patient was terminal on admission (n = 3 patients), data were recorded after brain death was diagnosed or PbtO2 was 0, data were recorded during dynamic tests such as autoregulation and hyperoxia tests, and data were missing, in part because of unintentional dislodging of one of the probes. Exclusion of data was distributed across the cohort. This left 75 patients in the study group; the general demographic, clinical, and physiological data for these patients are displayed in Tables 1 and 2 . Of these patients, 15 had monitors placed in the more-injured hemisphere, and the rest had monitoring either of the less injured hemisphere or right frontal as per standard protocol in patients who had diffuse brain injury, which made up the majority of patients in this cohort.
Time-Linked Relationship Between ICP and PbtO2
General Relationship Between ICP and PbtO2
Spearman's correlation using 8389 paired observations of hourly data in 75 patients (group A) for ICP and PbtO2 revealed a weak correlation between ICP and PbtO2 (r = 0.05, P , .01). The scatterplot for this relationship is shown in Figure 1 . Logistic regression analysis showed that higher values of ICP were associated with a lower probability of PbtO2 of 10 mm Hg or greater; however, this relationship also was weak (OR, 0.93; 95% CI, 0.92-0.94). In addition, when the GEE model was used, no significant relationship was observed between ICP and PbtO2 (P = .86). Results from Spearman's correlation for data analyzed using the continuous data set in 30 patients (group B, .1 million time points) were similar (r = 0.04, P , .05). When we examined only periods of hypotension (defined as mean arterial pressure less than the 5th percentile for age and sex; n = 46 093 data points from the continuous data, group B), the r value for this relationship was slightly higher (r = 0.19, P , .05). Whether patients had a craniotomy or craniectomy performed made no significant difference in the results. Ten patients underwent a craniotomy or craniectomy before monitoring was started, and a further 8 had surgery during the course of their monitoring. When we excluded these patients (excluded the former completely and excluded all data collected after surgery for the latter), the r value for the remaining patients was 0.02 (P . .05). There was no significant relationship observed between the ICP/PbtO2 correlation and outcome according to the Glasgow Outcome Score (P = .31). When we separately examined patients based on where the monitor had been placed, the r value for the ICP/PbtO2 relationship when the monitor was in the more injured hemisphere (n = 15) was 0.27 (P , .01), and in typical diffuse injury or the less injured hemisphere (n = 60) the r value was 0.01 (P = .67). To Relationship Between ICP and PbtO2 Controlled for Other Physiological Variables Linear regression analysis using ICP and PbtO2 data recorded concurrently with arterial blood gas observations (n = 400) did not demonstrate a relationship between PbtO2 and ICP (r = 20.11, P = .27). This analysis controlled for blood pressure, PaO 2 , PaCO 2 , and hemoglobin. Results from the GEE models were similar (Table 3 ). Figure 2 shows scatterplots for PbtO2 and CPP (using the continuous data set of group B) and PbtO2 against PaO 2 and PaCO 2 (using the arterial blood gas data set). Note that the r values of the scatterplots are different from the GEE values in Table 3 because the latter accounts for interindividual differences. Although PbtO2 is known to be strongly influenced by PaO 2 , the r value for this relationship was still relatively small, in part presumably because higher inspired fractions of oxygen were used as a treatment for low PbtO2 and was also more likely in patients who may have had increased ICP. The negative r value (nonsignificant) with PaCO 2 is interesting; however, this does not take into account interindividual differences. Also, even though increased CO 2 is associated with cerebral vasodilation, the effect on ICP caused by increased cerebral blood volume may compromise PbtO2. Table 4 shows the frequencies of PbtO2 data in each ICP category. The distribution of values for PbtO2 less than 5 mm Hg appears skewed to ICP values greater than 40 mm Hg, but these represent data from 3 patients and the total number of values for PbtO2 less than 5 mm Hg account only for 0.7% of the total data. Table 5 shows the sensitivities, specificities, and relative risks of ICP thresholds for reduced PbtO2. In general, the relative risk for reduced PbtO2 increased as the ICP threshold increased. The ROC curves for ICP in general demonstrated that the curves lay mostly close to the diagonal line, depicting a limited overall relationship between ICP and PbtO2. The 3 ROC curves are shown in Figure 3 . Using 1-mm Hg increments for the PbtO2 thresholds between 10 and 20 mm Hg in the ROC curve analysis did not change the result; no threshold yielded an area under the curve greater than 0.63.
Critical Threshold Values of ICP and PbtO2

Age-Related Thresholds
An age-related ICP threshold of X (6, 9, or 13 mm Hg, depending on the age category) detected 90.4% of PbtO2 episodes less than 10 mm Hg, ie 90% of observations of PbtO2 , 10 mm Hg occurred when ICP was above the age threshold, but this only had a specificity of 18.7%. This is possibly because the chosen ICP thresholds are very low. However, these are data that were reported for suggested age-corrected ICP thresholds in children. 28 Consistent with this, 81% of all ICP observations occurred at ICP values greater than the age threshold. ICP = (X 1 5) (11, 14, 18 mm Hg) had a sensitivity of 63.3% and a specificity of 46.3% for detecting episodes of PbtO2 less than 10 mm Hg. ICP = (X 1 10) (16, 19, or 23 mm Hg) detected 45.6% of cases with a specificity of 74.9%. The age-related ROCs, similar to those derived for the entire cohort, demonstrated a limited relationship between ICP and PbtO2.
ICP and PbtO2 in Individual Patients
ROC curves for individual patients showed significant variation but in general were not better than ROC curves for pooled data. For example, ROC curves for 2 individual patients revealed that the one patient had an ROC curve that lay above the diagonal (area = 0.64) and the other had an ROC curve below the diagonal (area = 0.27). These differences were typical of many patients. These data suggest that even for individual patients, the relationship between ICP and PbtO2 is complex.
Case Illustrations
Examination of electronic data revealed several different patterns in the relationship between ICP and PbtO2. A selected case (Figure 4) shows data for ICP, PbtO2, and mean arterial pressure recorded over 3 hours in a child with diffuse TBI and illustrates some of the variability in the relationship between ICP and PbtO2. Figure 4A shows a linear positive relationship between blood pressure and both ICP and PbtO2, as seen with impaired pressure autoregulation. Figure 4B demonstrates a linear positive relationship between ICP and PbtO2 because they both increase despite stable blood pressure. When the ICP subsequently increases to higher values, the relationship appears to change to a negative one ( Figure 4C ). This is followed by a much greater increase in ICP, which is associated with a significant reduction in PbtO2 ( Figure 4D ). This single case illustrates the temporal heterogeneity in TBI pathophysiology and the changing relationship between various physiological variables. Similar Figure 5A shows a typical negative response of PbtO2 to several large and sudden increases in ICP that were poorly controlled. The PbtO2 decreases immediately and to very low levels, highlighting the necessity of aggressive control of ICP needed in this patient. Figure 5B shows the trace of an 11-year-old boy and how even a moderate increase in ICP, well below the recommended treatment threshold, can affect PbtO2. Arguably, control of ICP at a lower threshold may benefit the patient, depending on the range of the PbtO2 decrease; however, if the PbtO2 change is within normal limits, perhaps this is an acceptable change that needs no intervention. In contrast to these inverse relationships between ICP and PbtO2, Figure 5C shows a parallel increase in both ICP and PbtO2 that was not related to a change in blood pressure and for which the cause was not identifiable. Figure 5D shows a steady increase in ICP that is associated initially with a steady PbtO2 increase. The PbtO2 direction then changes and becomes negative, presumably because the ICP has crossed a particular threshold (the line demonstrated in Figure 5D ), after which PbtO2 is influenced by the increasing tissue pressure effect. This may be helpful in recognizing a threshold at which the ICP becomes an influencing factor on PbtO2. However, in our experience, we see this commonly, but the threshold varies between patients and even in an individual at different times. Figure 5E shows an episode of increased ICP in which the PaCO 2 was decreased as a test of CO 2 responsiveness (decreased by 0.7 kPa). At the time of the CO 2 decrease (first line), the ICP promptly decreases and then increases again when the PaCO 2 was restored to baseline (second line). Despite the fact that decreasing PaCO 2 leads to vasoconstriction, here the PbtO2 and cerebral blood flow increase in response, presumably because of the effect of the reduced ICP. In this patient, a lower CO 2 may be of benefit at this point, keeping in mind that the circumstances may change over time. In our experience, a decrease in PaCO 2 can have different effects on PbtO2 and cerebral blood flow, depending on the prevailing physiology. Finally, Figure 5F illustrates a patient with impaired pressure auotregulation in whom blood pressure changes are followed passively by parallel changes in ICP and PbtO2. In this patient, optimal control of blood pressure in a narrow range is of critical importance, based on the ICP and PbtO2 response. Patients with intact autoregulation typically have a different response. Of interest, the correlation (r) between ICP and PbtO2 in Figure 5A was 20.78 (P , .01), and the correlation in Figure 5F was 0.9 (P , .01).
DISCUSSION
This study examined time-linked ICP and PbtO2 observations using several exploratory methods in 75 children with severe TBI. The main findings can be summarized as follows: (1) The overall relationship between ICP and PbtO2 is weak. Controlling for other factors that may affect PbtO2 did not improve this relationship. (2) The ICP-PbtO2 relationship varies among patients and within an individual patient over time. (3) Although a relationship between high ICP and low PbtO2 is observed at times in individual patients, specific threshold values for ICP are not predictive of low PbtO2. (4) There can be a strong negative relationship between ICP and PbtO2, but at times, there also may be a positive relationship depending on the underlying cerebral pathophysiology, such as cerebral hyperemia or impaired pressure autoregulation. Together these data suggest that the ICP-PbtO2 relationship is likely a complex relationship influenced by several factors. Although the main finding is negative, ie, a poor relationship between ICP and PbtO2, we believe this is important to further our understanding of the interaction between physiological variables in acute brain injury. From a practical standpoint, these data suggest that a simple linear relationship between ICP and PbtO2 cannot be assumed; when ICP is normal, PbtO2 may still be low, and when ICP is increased, the response of PbtO2 may be variable depending on the underlying pathophysiology and may, in some cases, be increased.
Time-Linked Relationship Between ICP and PbtO2
The overall correlation between ICP and PbtO2 was weak (r = 0.05). Although the nonlinear regression line showed a negative trend only at very high values of ICP, from our clinical experience (and see Figures 4 and 5D) , it is evident that increased ICP often may compromise PbtO2 and that this may occur at different ICP thresholds. During specific episodes, however, as demonstrated in our illustrations, the correlation between ICP can be strongly positive or negative, depending on the prevailing dynamics. Overall, however, the averaged relationship is weak, and controlling for several other systemic physiological variables showed no improvement of this result. Furthermore, ROC curves did not show a high diagnostic accuracy for any ICP level in detecting reduced PbtO2, even when age bands were taken into consideration or individual patients were examined. Although the relative risk of reduced PbtO2 did increase as the ICP threshold increased, very little of the variability in PbtO2 was attributable to ICP (R² = 0.01, in regression analysis). In general, as the ICP threshold increased, sensitivity for episodes of reduced PbtO2 decreased and specificity increased. An ICP threshold of 20 mm Hg detected only 42% of episodes of PbtO2 less than 10 mm Hg and 29% of PbtO2 less than 20 mm Hg. This suggests that in the context of normal ICP, other factors are commonly responsible for reduced PbtO2. Conversely, even when ICP was high, PbtO2 was not always reduced. In fact, when ICP was greater than 40 mm Hg (Table 4) , more than half of the PbtO2 observations were still greater than 20 mm Hg. Although in part this may reflect the influence of interventions to treat low PbtO2, it appears that other factors, such as hyperemia and impaired pressure autoregulation, may cause simultaneous increases in ICP and PbtO2.
Why Is the Relationship Between ICP and PbtO2
Variable and What Are the Implications?
There are several possible mechanisms in TBI that potentially influence the relationship between ICP and PbtO2. First, some factors may cause the expected opposite changes in ICP and PbtO2. For example, cerebral edema may increase ICP and decrease PbtO2 by the reduction in CPP or by increasing the diffusion distance of oxygen from the capillary to the cell. However, this relationship of increased ICP and reduced PbtO2 is not inevitable: our previous work suggests that almost one third of episodes of PbtO2 less than 10 mm Hg occur when patients appear to be optimally managed according to current guidelines. 18 Second, several physiological variables may influence PbtO2 independently of ICP, such as systemic oxygenation, cerebral vasospasm, and increased demand. Third, other factors may cause parallel changes in ICP and PbtO2, such as hyperemia, hypercarbia, and increased blood pressure (when pressure autoregulation is impaired). When the brain is more dysregulated, it is likely that the relationship between ICP and PbtO2 (and blood pressure) may be more strongly positive, certainly at lower levels of ICP. The results from the more injured hemisphere, in which the r value was higher (and significant despite a smaller sample), is in keeping with this. However, even in these patients the r value remains small, presumably because of the many other factors affecting this relationship.
An ICP monitor is recommended in patients with severe TBI and is considered a standard in most intensive care units. PbtO2 monitors were included in the adult Guidelines for Severe TBI in 2007 14 but are not yet standard of care. Emerging data from several centers suggest, however, that reduced PbtO2 is strongly associated with poor outcome in adults and children [11] [12] [13] 15, 29, 30 and that PbtO2 monitoring and treatment may benefit adult severe TBI patients when combined with ICP control. 17, 31, 32 The use of monitors of brain oxygenation, brain perfusion, and metabolism therefore has increased. 10, 24, [33] [34] [35] [36] [37] Appropriate use of these monitors may help interpret the pathophysiology underlying increased ICP in individual patients and help direct both the method of treating ICP and the threshold at which ICP should be treated. This may be of particular value in children for whom there is little evidence of appropriate thresholds for ICP treatment given their changing physiological profiles with age. 4 
Study Limitations
There are several potential limitations of this study. First, this was a retrospective study in a population treated for high ICP and reduced PbtO2; untreated ICP and PbtO2 may assume different relationships; however, this would be ethically unjustifiable and the results of this study therefore are relevant to patients being actively treated. This is a limitation of studying almost all variables in TBI and their relationships both with outcome and with other variables because there are very few monitors or results that we do not respond to. Although normal or high PbtO2 in the face of high ICP may be a treatment effect, in our experience, this is often not the case, and there may be several physiological reasons that explain a variable relationship between ICP and PbtO2. We have observed many patients in which ICP and PbtO2 simultaneously increase, which may reflect a hyperemic process; at other times, an increase in blood pressure has increased both ICP and PbtO2 in parallel in patients with impaired pressure autoregulation. Based on our clinical experience, we expect that even in the absence of any treatment for PbtO2, a similar result between ICP and PbtO2 would be obtained. Second, although age was considered in 3 bands, there are no robust data on what normal ICP is for all age categories or what constitutes significantly increased ICP for age. Despite the general belief that younger children should have ICP treated at lower thresholds, there is no evidence currently to develop firm recommendations for this practice. 23 Third, although all values of PbtO2 and ICP were time linked and therefore comparable, the use of hourly data may be limiting. However, analysis of data from individual patients with high-frequency data collection using more than 1 million time points were consistent with hourly analysis and revealed varying relationships between ICP and PbtO2, and ROC curves constructed with electronic data were not better than those using hourly data (data not shown). Fourth, the PbtO2 monitor used in this study examines a focal area of brain tissue. It is possible that data from a global measure of brain oxygenation may reveal different results. However, no reliable and continuous measure of global brain oxygenation currently exists, and there is some evidence to suggest that PbtO2 measured in relatively uninjured white matter reflects global changes. 38, 39 Fifth, PbtO2 may be affected by several variables. PbtO2 measures brain tissue oxygen tension and is therefore strongly influenced not only by cerebral blood flow (and other factors that influence cerebral blood flow), but also by arterial oxygen tension and the diffusion of oxygen through brain tissue. 40, 41 Although PbtO2 can decrease as CBF decreases, a PbtO2 monitor is not an ischemia monitor. 39, [42] [43] [44] [45] This may explain in part the dynamic variability in TBI, as there are many factors that influence ICP, brain perfusion, brain oxygenation, and brain metabolism. Our results are consistent with this. Still, even in the presence of many such factors, if ICP had a standard relationship with PbtO2, we believe that this would be evident in such a large analysis. Also, controlling for several other variables that we would expect to influence PbtO2 did not improve the results, nor did controlling for interindividual variability. Many other factors should be examined in detail with respect to their relationship to PbtO2, for example CPP. CPP is often considered to be as important as, or even more important than, ICP in children with TBI. Correlation between CPP and PbtO2 in this cohort was also weak, and we intend to examine this relationship in greater detail in a future study. Sixth, these results are relevant only to a pediatric population and may not apply to adult patients because there are differences in cerebrovascular pathophysiology in TBI between adults and children. 35, 46 However, a plot of the simple relationship between ICP and PbtO2 in 27 adult patients (n = 2821 observations) 29 showed a distribution similar to that of our results. In that study, even though high ICP increased the relative risk of low PbtO2, the number of observations of reduced PbtO2 was still 3 times greater when ICP was reduced than when it was high. Finally, several factors discussed here, such as autoregulation, time after injury and age, and perhaps other factors, such as cardiovascular and respiratory instability, may affect this relationship, and these are all worth detailed separate examination that is beyond the scope of this article, but highlights the heterogeneity of the population and informs further studies.
CONCLUSION
There is no Class I evidence to suggest that control of ICP or PbtO2 or the use of these monitors should be a standard of care for all severe TBI. Nevertheless, an ICP monitor often is considered standard in centers that treat TBI patients, and the frequency of PbtO2 monitoring is increasing. Our results suggest that the relationship between ICP and PbtO2 is variable and is likely dependent on several complex interactions. What determines PbtO2 and how best to treat compromised PbtO2 are only beginning to be elucidated. 32, 40, 41 Randomized, controlled trials are now planned for both ICP-and PbtO2-based care. However, until these studies are performed, we suggest that more data are required to understand the causes and nature of increased ICP and reduced PbtO2 and that current strategies to treat both need ongoing review. Perhaps the data also suggest how challenging these randomized, controlled trials may be, given the heterogeneity and complexity demonstrated in these patients.
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P. David Adelson
Phoenix, Arizona T he authors performed a retrospective study of 75 pediatric patients with severe traumatic brain injury (Glasgow Coma Scale score of #8) who underwent both ICP and PbtO2 monitoring. Analysis of time-linked ICP and PbtO2 values demonstrated weak overall relationship between the 2 metrics, and specific threshold ICP values that would be predicative of low PbtO2 could not be established. Instead of a simple linear correlation between ICP and PbtO2, the relationship varied among patients, and even in the same patient over time. There was also no significant relationship between the ICP/PbtO2 correlation and outcome.
The absence of a simple correlation between ICP and PbtO2 highlights the complex pathophysiology of TBI and the numerous variables, both intracranial and systemic, that can affect ICP, cerebral blood flow, and oxygenation. Reliance on ICP monitoring alone cannot reliably predict hypoxia of brain tissue. In their case illustrations, the authors' analysis of data points over time also emphasizes the dynamic nature of TBI. Therefore, the optimum management of TBI will most likely require multimodality monitoring over time rather than reliance on any singular measurement.
Michael Huang
San Francisco, California
